Employers Fear Squeeze From Genetic Cures That Cost Millions

Bookmark
(Bloomberg) -- Employers and health plans fear they could be swamped financially by a coming wave of expensive new genetic therapies for rare diseases.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.